Joseph McMahon is the current founder and chairman of Isolere Bio. Joseph has over two decades of experience in the biopharmaceutical industry, having served as president and CEO of KBI Biopharma from 2002 to 2016. During their time at KBI, McMahon led the company's growth from a startup to a global enterprise with three facilities and 450 employees. In 2015, they oversaw the sale of KBI Biopharma to JSR Corporation. McMahon continues to serve as a consultant to both KBI Biopharma and JSR Corporation, and they also served on the Board of Directors of kSep Systems until the company's sale to Sartorius in 2016. Prior to joining KBI Biopharma, McMahon served as Vice President of Diosynth from 1996 to 2002.